4//SEC Filing
Lo Andrew 4
Accession 0001209191-22-039256
CIK 0001743881other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:31 PM ET
Size
10.0 KB
Accession
0001209191-22-039256
Insider Transaction Report
Form 4
Lo Andrew
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-22+104,921→ 104,921 totalExercise: $8.45Exp: 2032-06-22→ Common Stock (104,921 underlying)
Footnotes (1)
- [F1]1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001679076
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:31 PM ET
- Size
- 10.0 KB